Hno International, INC

Market Movers (8-K)

OQB
HNO International amends prior filing to include details of a $62,500 financing agreement with Lambda Ventures, LLC, involving a convertible note and warrants.
Capital raise
OQB
HNO International, Inc. has entered into a Securities Purchase Agreement to issue a convertible promissory note and a common stock purchase warrant for gross proceeds of $62,500.
Capital raise
OQB
HNO International has entered into a $30 million equity purchase agreement with Lambda Ventures to provide flexible capital over the next 24 months.
Capital raise
OQB
HNO International, Inc. has entered into two separate financing agreements totaling $164,500 in net proceeds through convertible promissory notes and warrants.
Capital raise
OQB
HNO International, Inc. has dismissed Barton CPA, PLLC and appointed Green Growth CPAs as its new independent auditor.
OQB
HNO International, Inc. has entered into a Securities Purchase Agreement with CFI Capital LLC for a $150,000 convertible redeemable promissory note, yielding $133,000 in net proceeds.
Capital raise

Quarterly Earnings (10-Q)

OQB
HNO International, Inc. filed its Form 10-Q for the quarter ended April 30, 2026, detailing its financial performance and ongoing operations in the green hydrogen technology sector.
Capital raise
Worse than expected
OQB
HNO International, Inc. reported a significantly wider net loss for the nine months ended July 31, 2025, alongside a restatement of prior financial periods and ongoing concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
OQB
HNO International, Inc. filed an amendment to its quarterly report, correcting stock valuation which increased compensation expense by $4.8 million and deepened its net loss for the six months ended April 30, 2025.
Worse than expected
Delay expected
Capital raise
OQB
HNO International, Inc. filed an amended quarterly report to correct service stock valuation, leading to a significant increase in stock-based compensation expense and net loss.
Worse than expected
Delay expected
Capital raise
OQB
HNO International, a green hydrogen technology company, reported its inaugural revenue of $43,708 and a reduced quarterly net loss, but faces substantial doubt about its ability to continue as a going concern and disclosed material weaknesses in internal financial controls.
Worse than expected
Delay expected
Capital raise
OQB
HNO International reports no revenue and a net loss for Q1 2025, raising concerns about its ability to continue as a going concern.
Worse than expected
Capital raise

Annual Reports (10-K)

OQB
HNO International, a green hydrogen solutions provider, reported a significantly increased net loss for fiscal year 2025, highlighting ongoing liquidity challenges despite revenue growth and strategic project developments.
Worse than expected
Capital raise
Delay expected
OQB
HNO International, Inc. filed an amended annual report to correct service stock valuations, revealing increased stock-based compensation and a higher net loss for fiscal year 2024.
Worse than expected
Delay expected
Capital raise
OQB
HNO International, a green hydrogen technology company, reported a significant increase in net losses and a critical cash balance for fiscal year 2024, prompting a 'going concern' warning from its auditors and highlighting its heavy reliance on external financing.
Worse than expected
Capital raise
Delay expected
OQB
HNO International's Form 10-K filing reveals a widening net loss for fiscal year 2024, driven by increased operating expenses and a decrease in revenue, despite ongoing efforts to develop green hydrogen solutions.
Capital raise
Worse than expected
OQB
HNO International, a green hydrogen technology company, reported its fiscal year 2023 results, highlighting a focus on expanding its hydrogen production and refueling infrastructure despite ongoing financial challenges.
Worse than expected
Capital raise

Insider Trading (Form 4)

OQB
Donald W. Owens, CEO and Director of HNO International, Inc., reported significant transactions involving company common stock.
OQB
Donald W. Owens, CEO and Director of HNO International, Inc., reported significant transactions involving common stock.
OQB
Donald W. Owens, CEO, President, Secretary, Director, and 10% owner of HNO International, Inc. (HNOI), reported a gift of 450,000 shares of common stock.
OQB
HNO International's Treasurer, Hossein Haririnia, acquired 2 million shares of common stock at a price of $0.001 per share.
OQB
William E. Parker, a director of HNO International, Inc., acquired 2,000,000 shares of common stock at a price of $0.001 per share on December 23, 2024.
OQB
HNO International's CEO, Paul H Mueller, acquired 200,000 shares and disposed of 450,000 shares of common stock on November 15, 2024.

New Public Companies (S-1)

OQB
HNO International files a pre-effective amendment to its Form S-1 registration statement to include audited financial statements for the year ended October 31, 2023, and related management discussion.
Capital raise
Worse than expected